Dermira, Inc., a prominent biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for dermatological conditions. Founded in 2010, Dermira has made significant strides in the industry, particularly in the treatment of acne and other skin disorders. The company’s core products, including its flagship treatment for acne, are distinguished by their unique formulations and targeted delivery mechanisms, setting them apart in a competitive market. Dermira has established a strong market position, recognised for its commitment to advancing dermatological care through research and development. With a dedicated operational presence across major regions in the US, Dermira continues to drive innovation, aiming to improve the quality of life for patients suffering from skin conditions.
We don't have data for Dermira, Inc., but we can show you information about their parent organization instead.
View parent company